Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC-PMAT cells with TACE in advanced HCC
NCT02638857Phase 2Unknown
- Sponsor
- Naval Medical University
- Start
- Sep 2015
- Primary completion
- Mar 2017
- Modality
- Whole Cell Cancer Vaccines, Allogeneic CAR-T, TCR-Engineered T Cells
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dendritic cell-Cantonal Hospital of St. Gallen-prostate cancer and Precision Multiple Antigen T Cell in hepatocellular carcinoma (HCC), sponsored by Naval Medical University. Status: unknown.
02
Drugs
dendritic cell-Cantonal Hospital of St. Gallen-prostate cancerPrecision Multiple Antigen T Cell
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02638857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02638857.